Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet – Brands in India, Manufacturer & PCD Franchise (Reparon-V 0.5/0.3)
Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Meglitinide + biguanide / alpha-glucosidase inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Repaglinide 0.5 mg + Voglibose 0.3 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Part of our PCD pharma franchise range, available on a monopoly basis – see the general range PCD franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Repaglinide + voglibose Brands in India – Reparon-V 0.5/0.3 for PCD Franchise & Wholesale
Looking for repaglinide + voglibose brands in India? Trumac Healthcare markets repaglinide + voglibose as Reparon-V 0.5/0.3, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. Two mealtime agents in one tablet for post-prandial glucose; the 1/0.3 strength is the step-up.
It is part of the cardiac-diabetic PCD franchise (Ecron Life Sciences) range. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
Related brands
- Reparon-V 0.5/0.3 – repaglinide 0.5 mg + voglibose 0.3 mg, 10 x 10
- Reparon-V 1/0.3 – repaglinide 1 mg strength
- Glucim-V 2/0.3 – glimepiride + metformin + voglibose
- Full range: cardiac-diabetic PCD franchise (Ecron Life Sciences)
Ways to work with us
- PCD pharma franchise – repaglinide + voglibose under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which repaglinide + voglibose brands are available in India for PCD franchise?
Reparon-V 0.5/0.3 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply repaglinide + voglibose wholesale?
Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.
Which division is it part of?
The cardiac-diabetic (Ecron Life Sciences) division, which can be taken alone on monopoly for your district.
Can I get repaglinide + voglibose under my own brand?
Share your brand name, pack and quantity on WhatsApp and we will confirm availability and send a quotation.
Enquiry: Share your repaglinide + voglibose requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.
Therapeutic Indications
- Type-2 diabetes with post-prandial hyperglycaemia
- Patients with irregular meal patterns
- Elderly type-2 diabetics needing flexible glucose control
Mechanism of Action
Repaglinide is a meglitinide insulin secretagogue. It closes pancreatic beta-cell ATP-sensitive K+ channels (binding a different site than sulphonylureas), depolarising the cell and triggering insulin secretion. Short half-life produces a rapid, post-prandial insulin spike — useful for control of postprandial hyperglycaemia. Voglibose is an alpha-glucosidase inhibitor that delays intestinal carbohydrate absorption — synergistic for post-prandial control.
Dosage & Administration
- Adults: take 15–30 minutes before each main meal
- Skip dose if skipping meal
- Titrate based on glycaemic response
- Use under physician supervision
Side Effects
- Hypoglycaemia (less than long-acting sulphonylureas)
- Weight gain (mild)
- GI upset
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Severe hepatic impairment
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet?
MRPs range from ₹1690 to ₹1690 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet?